BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 233 filers reported holding BEAM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $874 | -20.0% | 36,325 | +6.1% | 0.00% | – |
| Q2 2023 | $1,093 | +16.6% | 34,225 | +12.0% | 0.00% | – |
| Q1 2023 | $937 | -19.1% | 30,569 | +3.3% | 0.00% | – |
| Q4 2022 | $1,158 | -99.9% | 29,598 | +9.4% | 0.00% | – |
| Q3 2022 | $1,289,000 | +41.8% | 27,045 | +15.2% | 0.00% | – |
| Q2 2022 | $909,000 | -27.7% | 23,485 | +7.1% | 0.00% | – |
| Q1 2022 | $1,257,000 | -16.1% | 21,936 | +16.7% | 0.00% | – |
| Q4 2021 | $1,498,000 | -25.8% | 18,800 | -18.9% | 0.00% | – |
| Q3 2021 | $2,018,000 | -39.4% | 23,193 | -10.4% | 0.00% | – |
| Q2 2021 | $3,332,000 | -19.7% | 25,884 | -50.1% | 0.00% | – |
| Q1 2021 | $4,148,000 | +398.6% | 51,823 | +408.4% | 0.00% | – |
| Q4 2020 | $832,000 | -93.3% | 10,193 | -97.7% | 0.00% | -100.0% |
| Q2 2020 | $12,445,000 | +51.5% | 444,449 | -2.6% | 0.00% | +100.0% |
| Q1 2020 | $8,216,000 | – | 456,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |